Meaghan Buisson agreed to take part in a clinical trial on the use of MDMA for treating post-traumatic stress disorder after what she calls a “year of darkness.” She says she was not warned about the documented dangers of sexual exploitation.
As psychedelic therapy goes mainstream, former patient warns of danger of sexual abuse
